Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PONIARD PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: PARD

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.800 Hold 10
    30 Days Ago 1.455 Strong Buy 11
    60 Days Ago 1.400 Strong Buy 10
    90 Days Ago 1.400 Strong Buy 10
    120 Days Ago 1.111 Strong Buy 9

  • Analyst Ratings: PARD

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Canaccord Adams Buy Hold 11/18/2009 —
    Wedbush Morgan Outperform Underperform 11/17/2009 —
    Rodman & Renshaw Mkt Outperform Mkt Perform 11/16/2009 —
    Needham Buy Hold 11/16/2009 —
    Merriman Buy Neutral 11/16/2009 —
    BMO Capital Markets — Outperform 10/06/2009 —
    Brean Murray — Buy 07/02/2009 11.00
    Wedbush Morgan — Buy 03/20/2009 6.00
    Needham — Buy 03/18/2009 6.00
    Lazard Capital — Buy 02/09/2009 6.00
    Oppenheimer — Outperform 12/01/2008 8.00
    Credit Suisse — Outperform 10/03/2007 10.00
    Oppenheimer — Buy 06/21/2007 13.00
    Rodman & Renshaw — Mkt Outperform 06/04/2007 10.00
    Lazard Capital — Buy 05/07/2007 11.00
    CIBC Wrld Mkts — Sector Outperform 05/07/2007 13.00
    Cantor Fitzgerald — Buy 03/16/2007 12.00
    Fortis Bank — Buy 03/08/2007 8.00
    Rodman & Renshaw — Mkt Outperform 01/29/2007 7.00
    Cantor Fitzgerald — Buy 11/29/2006 9.00